
Cancer Biology & Genetics Program
The Tuomas Tammela Lab
Research

The Tammela lab is interested in understanding the remarkable phenotypic heterogeneity of cancer cells within tumors. We approach this question using a combination of sophisticated genetically engineered mouse models, single-cell approaches, tracing and ablation of distinct tumor cell lineages, CRISPR-mediated gene regulation, and advanced imaging techniques. We utilize the exceptional resources developed by our MSK collaborators, such as organoids and xenografts, for the translation of our findings into new treatments for human cancer. Our goal is to discover pathways that drive distinct cellular phenotypes and to develop new therapeutic concepts aimed at reducing cellular heterogeneity in tumors.
Research Projects
Inside My Lab: Tuomas Tammela

Featured News


Publications
People

Tuomas Tammela, MD, PhD
- Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung and pancreatic cancers.
- Massachusetts Institute of Technology: Postdoctoral Fellowship
- University of Helsinki, Finland: MD, PhD
- 646-888-2048
- Office Phone
Members




Lab Manager

GSK Graduate Student; Harold Varmus Scholar in Cancer Biology

Clinical Instructor

Research Technician

PhD Student

Postdoctoral Fellow

PhD Student

Clinical Fellow

Research Technician

Senior Research Technician

MD-PhD Student; Kirschstein National Research Service Award (F30) Fellow

Postdoctoral Fellow; NYSTEM Training Award at the Center for Stem Cell Biology (CSCB)










Lab Alumni

M.D. Student, Icahn School of Medicine at Mount Sinai

Ph.D. Student, Computational Biology Program, Albert Einstein College of Medicine

Senior Principal Scientist, Clinical Biomarker Development at Loxo Oncology/Lilly

Ph.D. Student, Stanford University

Postdoctoral Fellow, Karolinska Institute, Sweden

M.D./Ph.D. Student, University of Miami

Clinical Research Project Coordinator, MSKCC Pediatrics

Scientist II, Computational Biology, GC Therapeutics

MD, PhD, Assistant Professor, Department of Radiation Oncology, OSUCCC, Columbus, Ohio

M.D./Ph.D. Student, New York University

Assistant Professor, Wuhan Agricultural University
Lab Affiliations
- Cancer Biology & Genetics Program
- Fiona and Stanley Druckenmiller Center for Lung Cancer Research
- Center for Stem Cell Biology
- David M. Rubenstein Center for Pancreatic Cancer Research
- PhD Programs in Computational Biology & Medicine
- MD/PhD Program
- Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Achievements
- Josie Robertson Investigator (2017-2022)
- The Mark Foundation Emerging Leader Award (2021)
- Rita Allen Foundation Scholar (2020)
- National Cancer Institute R37 MERIT Award (2020)
- American Cancer Society Scholar (2020)
Read more
- V Foundation Scholar (2019)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
Get in Touch
-
Office Phone
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tuomas Tammela discloses the following relationships and financial interests:
-
Gerson Lehrman Group
Provision of Services
-
Guidepoint Global Advisors
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].